Atherosclerosis (peripheral vessels)

ABC of arterial and venous disease: Chronic lower limb ischaemia.
[10731185] BMJ 320(7238): 854-7 (2000)

ABC of vascular diseases. Critical leg ischaemia: amputation or reconstruction.
[1531431] BMJ 304(6822): 312-4 (1992)

Peripheral arterial disease: current perspectives and new trends in management.
[19864983] South Med J 102(11): 1141-9 (2009)

Contemporary management of peripheral arterial disease: III. Endovascular and surgical management.
[17385391] Cleve Clin J Med 73 Suppl 4(-): S45-51 (2006)

Contemporary management of peripheral arterial disease: II. Improving walking distance and quality of life.
[17385390] Cleve Clin J Med 73 Suppl 4(-): S38-44 (2006)

Contemporary management of peripheral arterial disease: I. Cardiovascular risk-factor modification.
[17385389] Cleve Clin J Med 73 Suppl 4(-): S30-7 (2006)

Noninvasive diagnostic strategies for peripheral arterial disease.
[17385388] Cleve Clin J Med 73 Suppl 4(-): S22-9 (2006)

The clinical presentation of peripheral arterial disease and guidance for early recognition.
[17385387] Cleve Clin J Med 73 Suppl 4(-): S15-21 (2006)

Pathophysiology of peripheral arterial disease and risk factors for its development.
[17385386] Cleve Clin J Med 73 Suppl 4(-): S8-14 (2006)

Peripheral arterial disease: recognition and medical management.
[16845974] Cleve Clin J Med 73(7): 621-6, 628, 632-4, passim (2006)

Management of peripheral arterial disease in the elderly: focus on cilostazol.
[18488875] Clin Interv Aging 3(1): 17-23 (2008)

Critical review of the ankle brachial index.
[19936284] Curr Cardiol Rev 4(2): 101-6 (2008)

Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC).
[10666287] J Vasc Surg 31(1 Pt 2): S1-S296 (2000)

Primary nitinol stenting for femoropopliteal disease.
[19624075] J Endovasc Ther 16(2 Suppl 2): II63-81 (2009)

Medical and endovascular management of critical limb ischemia.
[19624074] J Endovasc Ther 16(2 Suppl 2): II31-62 (2009)

TASC II and the endovascular management of infrainguinal disease.
[19624072] J Endovasc Ther 16(2 Suppl 2): II5-18 (2009)

Past, present and future of femoropopliteal stenting.
[19317587] J Endovasc Ther 16 Suppl 1(-): I147-52 (2009)

Infrapopliteal stents: overview and unresolved issues.
[19317574] J Endovasc Ther 16 Suppl 1(-): I153-62 (2009)

Contemporary endovascular treatment for disease of the superficial femoral and popliteal arteries: an integrated device-based strategy.
[16472010] J Endovasc Ther 13 Suppl 2(-): II41-51 (2006)

Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries.
[16472009] J Endovasc Ther 13 Suppl 2(-): II30-40 (2006)

Diagnosis and risk assessment of lower extremity peripheral arterial disease.
[16472008] J Endovasc Ther 13 Suppl 2(-): II10-8 (2006)

Epidemiology and pathophysiology of lower extremity peripheral arterial disease.
[16472007] J Endovasc Ther 13 Suppl 2(-): II3-9 (2006)

Percutaneous transluminal angioplasty in the treatment of critical limb ischemia.
[12877613] J Endovasc Ther 10(2): 298-303 (2003)

The role of thrombolytic therapy in the management of acute and chronic lower extremity ischemia.
[10772751] J Endovasc Ther 7(1): 72-7 (2000)

Percutaneous transluminal angioplasty of the subclavian arteries.
[10088888] J Endovasc Surg 6(1): 33-41 (1999)

Risk reduction with clopidogrel in the management of peripheral arterial disease.
[17703636] Vasc Health Risk Manag 3(3): 289-97 (2007)

A systematic review of duplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease.
[17462170] Health Technol Assess 11(20): iii-iv, xi-xiii, 1-184 (2007)

The cost-effectiveness of magnetic resonance angiography for carotid artery stenosis and peripheral vascular disease: a systematic review.
[12022939] Health Technol Assess 6(7): 1-155 (2002)

Peripheral arterial disease: a guide for nephrologists.
[17699501] Clin J Am Soc Nephrol 2(4): 839-46 (2007)

Selection of level for lower limb amputation in patients with severe peripheral vascular disease.
[2042890] Ann R Coll Surg Engl 73(3): 148-51 (1991)

Endovascular surgery for peripheral arterial occlusive disease. A critical review.
[1385944] Ann Surg 216(1): 3-16 (1992)

Axillofemoral bypass: a ten-year review.
[6211151] Ann Surg 195(6): 796-9 (1982)

Review of Criteria for the Selection of the Level for Lower Extremity Amputation for Arteriosclerosis.
[17859794] Ann Surg 162(5): 886-92 (1965)

ACP Journal Club. Review: computed tomography angiography is highly accurate for diagnosing significant stenosis in peripheral arterial disease.
[19451568] Ann Intern Med 150(10): JC5-12 (2009)

In the clinic. Peripheral arterial disease.
[17339616] Ann Intern Med 146(5): ITC3-1-ITC3-16 (2007)

Antithrombotic therapy for peripheral artery occlusive disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
[18574279] Chest 133(6 Suppl): 815S-843S (2008)

Atherosclerotic Peripheral Vascular Disease Symposium II: lower-extremity revascularization: state of the art.
[19106409] Circulation 118(25): 2864-72 (2008)

Atherosclerotic Peripheral Vascular Disease Symposium II: vascular magnetic resonance and computed tomographic imaging.
[19106405] Circulation 118(25): 2837-44 (2008)

Endovascular therapies for peripheral arterial disease: an evidence-based review.
[17984390] Circulation 116(19): 2203-15 (2007)

Overview of new technologies for lower extremity revascularization.
[17967988] Circulation 116(18): 2072-85 (2007)

Peripheral arterial disease: morbidity and mortality implications.
[16908785] Circulation 114(7): 688-99 (2006)

ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.
[16549646] Circulation 113(11): e463-654 (2006)

Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review.
[8941154] Circulation 94(11): 3026-49 (1996)

Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Vascular Clinical Trialists.
[7634476] Circulation 92(3): 614-21 (1995)

Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials.
[19028778] Eur Heart J 30(1): 44-55 (2009)

Lower-extremity peripheral arterial disease among patients with end-stage renal disease.
[11729255] J Am Soc Nephrol 12(12): 2838-47 (2001)

Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis.
[19176443] JAMA 301(4): 415-24 (2009)

Medical treatment of peripheral arterial disease.
[16449620] JAMA 295(5): 547-53 (2006)

Magnetic resonance angiography for the evaluation of lower extremity arterial disease: a meta-analysis.
[11255390] JAMA 285(10): 1338-45 (2001)

Peripheral arterial disease: diagnosis and management.
[18674479] Mayo Clin Proc 83(8): 944-49; quiz 949-50 (2008)

Treatment of the critically ischaemic lower limb.
[8140023] Postgrad Med J 70(819): 5-9 (1994)

Angioplasty in peripheral vascular disease.
[2963265] Postgrad Med J 63(740): 435-8 (1987)

Update on endovascular treatment of peripheral vascular disease: new tools, techniques, and indications.
[11198311] Tex Heart Inst J 27(4): 369-85 (2000)

Current concepts in the evaluation of vascular disease: magnetic resonance and computed tomographic angiography.
[10928506] Tex Heart Inst J 27(2): 170-92 (2000)

State of the art: which stent for which lesion in peripheral interventions?
[10928499] Tex Heart Inst J 27(2): 119-26 (2000)

Chronic lower limb ischemia.
[10903303] West J Med 173(1): 60-3 (2000)

Current treatment of peripheral arterial disease: role of percutaneous interventional therapies.
[17678729] J Am Coll Cardiol 50(6): 473-90 (2007)

ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.
[16545667] J Am Coll Cardiol 47(6): 1239-312 (2006)

The role of infrapopliteal angioplasty.
[15569642] Br J Radiol 77(924): 1007-15 (2004)

MR angiography of the lower extremities.
[18492924] AJR Am J Roentgenol 190(6): 1675-84 (2008)

Assessment of critical limb ischemia in patients with diabetes: comparison of MR angiography and digital subtraction angiography.
[16304027] AJR Am J Roentgenol 185(6): 1641-50 (2005)

Diabetes and peripheral arterial occlusive disease: prospective comparison of contrast-enhanced three-dimensional MR angiography with conventional digital subtraction angiography.
[10628475] AJR Am J Roentgenol 174(1): 171-9 (2000)

Multidetector CT angiography of infrainguinal arterial bypass.
[18349456] Radiographics 28(2): 529-48; discussion 549 (2008)

Popliteal artery disease: diagnosis and treatment.
[15026594] Radiographics 24(2): 467-79 (2004)

Optimized diagnostic angiography in high-risk patients with severe peripheral vascular disease.
[10682777] Radiographics 20(1): 121-33 (2000)

Peripheral arterial disease: comparison of color duplex US and contrast-enhanced MR angiography for diagnosis.
[15858107] Radiology 235(2): 699-708 (2005)

MR angiography in the evaluation of atherosclerotic peripheral vascular disease.
[10671577] Radiology 214(2): 325-38 (2000)

Treatment of peripheral vascular disease with stent-grafts.
[9356607] Radiology 205(2): 307-14 (1997)

The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis.
[17933075] Acta Med Indones 39(2): 86-93 (2007)

The counter-regulation of atherogenesis: a role for interleukin-33.
[21171524] Acta Medica (Hradec Kralove) 53(3): 125-9 (2010)

Vascular calcification in animal models of CKD: A review.
[20413965] Am J Nephrol 31(6): 471-81 (2010)

Novel therapies for cyclic GMP control of vascular smooth muscle growth.
[19127140] Am J Ther 15(6): 551-64 (2008)

Osteogenic regulation of vascular calcification: an early perspective.
[15102615] Am J Physiol Endocrinol Metab 286(5): E686-96 (2004)

Intermittent claudication.
[17095782] BMJ 333(7576): 1002-5 (2006)

Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data.
[19276131] BMJ 338(-): b603 (2009)

Lipid peroxidation and decomposition--conflicting roles in plaque vulnerability and stability.
[18406361] Biochim Biophys Acta 1781(5): 221-31 (2008)

Bilirubin and biliverdin treatment of atherosclerotic diseases.
[17245120] Cell Cycle 6(1): 39-43 (2007)

Conditional risk factors for atherosclerosis.
[15704777] Mayo Clin Proc 80(2): 219-30 (2005)

Immunomodulatory effects of statins: mechanisms and potential impact on arteriosclerosis.
[12039998] J Am Soc Nephrol 13(6): 1673-81 (2002)

Vascular calcification: the three-hit model.
[19470670] J Am Soc Nephrol 20(6): 1162-4 (2009)

Neovascularization in human atherosclerosis.
[16684874] Circulation 113(18): 2245-52 (2006)

Phospholipid transfer protein and atherosclerosis: genetic studies take aim at a moving target.
[20644011] Circulation 122(5): 452-4 (2010)

Inflammation in peripheral artery disease.
[21041698] Circulation 122(18): 1862-75 (2010)

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.
[14530185] Circulation 108(14): 1664-72 (2003)

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.
[14557340] Circulation 108(15): 1772-8 (2003)

Membrane microdomains and vascular biology: emerging role in atherogenesis.
[12732593] Circulation 107(17): 2270-3 (2003)

Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications.
[17938300] Circulation 116(16): 1832-44 (2007)

Mast cells as mediators and modulators of atherogenesis.
[17502588] Circulation 115(19): 2471-3 (2007)

Childhood infection and endothelial dysfunction: a potential link in atherosclerosis?
[15811865] Circulation 111(13): 1568-70 (2005)

Insights into the role of infection in atherogenesis and in plaque rupture.
[19546396] Circulation 119(24): 3133-41 (2009)

Bone-marrow-derived matrix metalloproteinase-14: a novel target for plaque stability.
[18285576] Circulation 117(7): 863-5 (2008)

Buflomedil in peripheral arterial disease: trials and tribulations.
[18268159] Circulation 117(6): 717-9 (2008)

Understanding the essential role of monocytes in atherosclerosis.
[20558886] Circ J 74(7): 1292-3 (2010)

Role of peroxisome proliferator-activated receptor-γ in atherosclerosis: an update.
[21325726] Circ J 75(3): 528-35 (2011)

Advances in endovascular treatment of critical limb ischemia.
[21422665] Circ J 75(4): 756-65 (2011)

Macrophages, oxysterols and atherosclerosis.
[20838002] Circ J 74(10): 2045-51 (2010)

Critical balance of dendritic cells is destined for plaque rupture.
[19779274] Circ J 73(10): 1799-800 (2009)

Serial intravascular ultrasound assessment of atherosclerosis progression and regression. State-of-the-art and limitations.
[19638706] Circ J 73(9): 1557-60 (2009)

Targeting interferon-gamma to treat atherosclerosis.
[17702979] Circ Res 101(4): 333-4 (2007)

Selective depletion of macrophages in atherosclerotic plaques: myth, hype, or reality?
[17395878] Circ Res 100(6): 751-3 (2007)

Atherosclerosis and thrombosis: insights from large animal models.
[21274431] J Biomed Biotechnol 2011(-): 907575 (2011)

Microregulation of plaque neovascularization.
[20631347] Arterioscler Thromb Vasc Biol 30(8): 1500-1 (2010)

Concept of vulnerable/unstable plaque.
[20554950] Arterioscler Thromb Vasc Biol 30(7): 1282-92 (2010)

Lesion macrophages are a key target for the antiatherogenic effects of LXR agonists.
[15626767] Arterioscler Thromb Vasc Biol 25(1): 10-1 (2005)

Discovery of the role of wall shear in atherosclerosis.
[19038849] Arterioscler Thromb Vasc Biol 29(2): 158-61 (2009)

Mouse models for atherosclerosis and pharmaceutical modifiers.
[17541027] Arterioscler Thromb Vasc Biol 27(8): 1706-21 (2007)

Inflammation imaging in atherosclerosis.
[19304673] Arterioscler Thromb Vasc Biol 29(7): 1009-16 (2009)

Assessment of unstable atherosclerosis in mice.
[17332492] Arterioscler Thromb Vasc Biol 27(4): 714-20 (2007)

PLA2-V: a real player in atherogenesis.
[17301321] Arterioscler Thromb Vasc Biol 27(3): 445-7 (2007)

Role of caspases in death and survival of the plaque macrophage.
[15718496] Arterioscler Thromb Vasc Biol 25(5): 895-903 (2005)

Molecular imaging of macrophage cell death for the assessment of plaque vulnerability.
[19461053] Arterioscler Thromb Vasc Biol 29(7): 1031-8 (2009)

Correlation between carotid intimal/medial thickness and atherosclerosis: a point of view from pathology.
[19679833] Arterioscler Thromb Vasc Biol 30(2): 177-81 (2010)

The discovery of cellular immunity in the atherosclerotic plaque.
[19846836] Arterioscler Thromb Vasc Biol 29(11): 1714-7 (2009)

Sphingosine 1-phosphate: a regulator of arterial lesions.
[19592471] Arterioscler Thromb Vasc Biol 29(10): 1439-43 (2009)

Role of smooth muscle cells in the initiation and early progression of atherosclerosis.
[18276911] Arterioscler Thromb Vasc Biol 28(5): 812-9 (2008)

On to the road to degradation: atherosclerosis and the proteasome.
[19815565] Cardiovasc Res 85(2): 291-302 (2010)

CD36 and macrophages in atherosclerosis.
[17442283] Cardiovasc Res 75(3): 468-77 (2007)

Phagocytosis in atherosclerosis: Molecular mechanisms and implications for plaque progression and stability.
[17084825] Cardiovasc Res 73(3): 470-80 (2007)

Early atherosclerosis in humans: role of diffuse intimal thickening and extracellular matrix proteoglycans.
[18430750] Cardiovasc Res 79(1): 14-23 (2008)

Activating SIRT1: a new strategy to prevent atherosclerosis?
[18784217] Cardiovasc Res 80(2): 163-4 (2008)

The unstable plaque: a broken balance.
[19561341] Eur Heart J 30(15): 1821-3 (2009)

Imaging of the unstable plaque: how far have we got?
[19833636] Eur Heart J 30(21): 2566-74 (2009)

Inflammation and atherosclerosis: novel insights into plaque formation and destabilization.
[16741184] Stroke 37(7): 1923-32 (2006)

From endothelial dysfunction to vascular occlusion: role of the renin-angiotensin system.
[20866008] Rev Port Cardiol 29(5): 801-24 (2010)

Footprints of atherosclerotic coronary heart disease in children.
[15058151] Rev Port Cardiol 23(1): 127-31 (2004)

Endothelial function and atherosclerosis: circulatory markers with clinical usefulness.
[20058778] Rev Port Cardiol 28(10): 1121-51 (2009)

The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?
[20371550] J Lipid Res 51(8): 2058-73 (2010)

The LDL modification hypothesis of atherogenesis: an update.
[19011257] J Lipid Res 50 Suppl(-): S376-81 (2009)

Thematic review series: The immune system and atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis.
[15654120] J Lipid Res 46(3): 404-11 (2005)

Thematic review series: the immune system and atherogenesis. The unusual suspects:an overview of the minor leukocyte populations in atherosclerosis.
[15772419] J Lipid Res 46(5): 829-38 (2005)

Myeloperoxidase, modified lipoproteins, and atherogenesis.
[19091698] J Lipid Res 50 Suppl(-): S346-51 (2009)

The role of adaptive T cell immunity in atherosclerosis.
[19050311] J Lipid Res 50 Suppl(-): S364-9 (2009)

Mechanisms and consequences of macrophage apoptosis in atherosclerosis.
[18953058] J Lipid Res 50 Suppl(-): S382-7 (2009)

The role of dysfunctional HDL in atherosclerosis.
[18955731] J Lipid Res 50 Suppl(-): S145-9 (2009)

Emerging role of Toll-like receptors in atherosclerosis.
[18980945] J Lipid Res 50 Suppl(-): S340-5 (2009)

Immune mechanisms in atherosclerosis and potential for an atherosclerosis vaccine.
[21616039] Discov Med 11(60): 403-12 (2011)

Role of monocytes in atherogenesis.
[14506301] Physiol Rev 83(4): 1069-112 (2003)

Autophagy of vascular smooth muscle cells in atherosclerotic lesions.
[17172800] Autophagy 3(1): 63-4 (2007)

A two-carbon switch to sterol-induced autophagic death.
[17172803] Autophagy 3(1): 38-41 (2007)

Role of cell adhesion molecules and immune-cell migration in the initiation, onset and development of atherosclerosis.
[19262139] Cell Adh Migr 1(4): 171-5 (2007)

Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction.
[18160725] Clin Chem 54(1): 24-38 (2008)

Peripheral arterial disease: prognostic significance and prevention of atherothrombotic complications.
[15287833] Med J Aust 181(3): 150-4 (2004)

The role of inflammation, humoral and cell mediated autoimmunity in the pathogenesis of atherosclerosis.
[18803034] Swiss Med Wkly 138(37-38): 534-9 (2008)

Role of infrainguinal angioplasty in the treatment of critical limb ischaemia.
[17461306] Scand J Surg 96(1): 11-6 (2007)

Preclinical models of human peripheral arterial occlusive disease: implications for investigation of therapeutic agents.
[15107408] J Appl Physiol 97(2): 773-80 (2004)

Interleukin 17 in vascular inflammation.
[21075042] Cytokine Growth Factor Rev 21(6): 463-9 (2010)

Macrophage death and defective inflammation resolution in atherosclerosis.
[19960040] Nat Rev Immunol 10(1): 36-46 (2010)

Matrix-metalloproteinases as imaging targets for inflammatory activity in atherosclerotic plaques.
[20439506] J Nucl Med 51(5): 663-6 (2010)

Imaging atherosclerosis and vulnerable plaque.
[20395341] J Nucl Med 51 Suppl 1(-): 51S-65S (2010)

The vascular biology of atherosclerosis and imaging targets.
[20395349] J Nucl Med 51 Suppl 1(-): 33S-37S (2010)

Diagnosis and treatment options for the infrapopliteal peripheric arterial occlusive diseases.
[19103542] Anadolu Kardiyol Derg 8(6): 449-50 (2008)

Endovascular treatment of femoral-popliteal disease.
[21326540] Semin Intervent Radiol 26(4): 303-14 (2009)

Biomarkers of peripheral arterial disease.
[20447524] J Am Coll Cardiol 55(19): 2017-23 (2010)

Intravascular brachytherapy for peripheral vascular disease.
[21289914] GMS Health Technol Assess 4(-): Doc08 (2008)

Management of lower extremity peripheral arterial disease.
[19008688] J Cardiopulm Rehabil Prev 28(6): 349-57 (2008)

Our treatment strategy for critical limb ischemia.
[24386568] Int J Vasc Med 2013():437471 (2013)

Systemic delivery of miR-126 by miRNA-loaded Bubble liposomes for the treatment of hindlimb ischemia.
[24457599] Sci Rep 4():3883 (2014)

MRI in Lower Extremity Peripheral Arterial Disease: Recent Advancements.
[23336015] Curr Cardiovasc Imaging Rep 6(1):55-60 (2013)

Outcomes of lower extremity bypass performed for acute limb ischemia.
[23714364] J Vasc Surg 58(4):949-56 (2013)

An overview of optimal endovascular strategy in treating the femoropopliteal artery: mechanical, biological, and procedural factors.
[24436577] Int J Angiol 22(1):1-8 (2013)

Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival in patients with critical limb ischemia.
[24315911] J Am Coll Cardiol 63(7):682-90 (2014)

Challenges associated with peripheral arterial disease in women.
[24648743] Vasc Health Risk Manag 10():115-28 (2014)

Efficacy of a novel method of intravenous infusion of the prostaglandin analogue iloprost for the treatment of lower-limb critical ischemia: An open-label, nonrandomized study in two cohorts.
[24672081] Curr Ther Res Clin Exp 65(3):255-65 (2004)

Emerging Stent and Balloon Technologies in the Femoropopliteal Arteries.
[24672355] ScientificWorldJournal 2014(): (2014)

Proceedings from the Society of Interventional Radiology research consensus panel on critical limb ischemia.
[23522155] J Vasc Interv Radiol 24(4):451-8 (2013)

Multilevel versus isolated endovascular tibial interventions for critical limb ischemia.
[21803523] J Vasc Surg 54(3):722-9 (2011)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Atherosclerosis (peripheral vessels).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Atherosclerosis (peripheral vessels).php on line 92